Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y | YTD ▲ | 3y | 5y |
---|---|---|---|---|---|---|---|
Heron Therapeutics Inc. | 6.450% | -0.336% | 0.000% | 17.525% | 51.210% | -83.656% | - |
UCB S.A. | 0.450% | -2.951% | 5.780% | 44.024% | 54.559% | 57.683% | 73.461% |
Natera Inc | 0.570% | 2.339% | 2.339% | 93.584% | 54.867% | - | - |
Vivani Medical Inc. | -2.610% | -3.165% | -13.068% | 30.769% | 56.923% | - | - |
MacroGenics Inc. | 4.470% | -3.138% | 14.980% | 127.200% | 57.778% | -47.310% | - |
Brainstorm Cell | 5.560% | -26.131% | -44.654% | -86.685% | 58.405% | -87.328% | - |
Deciphera Pharmaceuticals | - | 77.273% | 61.379% | 82.243% | 59.238% | -38.095% | - |
Protara Therapeutics Inc. | 2.820% | -5.517% | -27.513% | -5.517% | 65.060% | -89.388% | - |
ImmunityBio Inc. | 9.440% | 75.415% | 71.066% | 200.288% | 76.864% | -43.488% | - |
Adaptimmune Therapeutics PLC ADR | -0.900% | 12.121% | -13.953% | -10.484% | 77.600% | -76.282% | - |
Geron Corp. | 1.710% | 10.683% | 28.332% | 62.169% | 86.890% | 205.990% | 137.290% |
Guerbet S.A. | -0.400% | 6.259% | 13.354% | 124.190% | 93.724% | 8.418% | -28.857% |
MorphoSys AG | 0.680% | -2.066% | -1.191% | 251.523% | 94.575% | -15.628% | -25.449% |
Mediwound Ltd. | 2.820% | 9.259% | 38.281% | 78.788% | 96.667% | 383.607% | 280.645% |
XBiotech Inc | 6.340% | 0.709% | -2.069% | 129.032% | 100.565% | -49.965% | -12.497% |
Chromadex Corp | 1.810% | 10.759% | 4.790% | 180.000% | 161.194% | -51.389% | - |
Cytomx Therapeutics Inc | -0.140% | 178.476% | 111.044% | 178.476% | 198.424% | -46.452% | - |
Cardiff Oncology Inc. | -3.130% | 9.249% | -18.090% | 149.694% | 209.650% | -48.418% | 16.429% |
Nektar Therapeutics | 2.640% | 25.668% | 74.089% | 126.569% | 211.584% | -90.637% | - |
Alpine Immune Sciences Inc | -0.830% | 0.000% | 65.301% | 830.769% | 237.989% | 587.500% | 643.974% |
Viking Therapeutics Inc | -5.100% | 10.031% | -1.698% | 270.425% | 304.003% | 1227.820% | - |
Corbus Pharmaceuticals Holding Inc. | 4.620% | 13.376% | 2.299% | 27582.737% | 27582.737% | -23.292% | - |